Citations (49)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Takeshi Takamoto, Yuta Maruki & Shunsuke Kondo. (2023) Recent updates in the use of pharmacological therapies for downstaging in patients with hepatocellular carcinoma. Expert Opinion on Pharmacotherapy 24:14, pages 1567-1575.
Read now
Read now
Jing-Xuan Xu, Wan-Ting Xing, Yu-Chong Peng, Yuan-Yuan Chen & Lu-Nan Qi. (2022) Outcomes of postoperative adjuvant transarterial chemoembolization for hepatocellular carcinoma according to the Ki67 index. Future Oncology 18:17, pages 2113-2125.
Read now
Read now
Lei Wang, Qiao Ke, Kongying Lin, Jingbo Chen, Ren Wang, Chunhong Xiao, Xiaolong Liu & Jingfeng Liu. (2020) Not All Hepatocellular Carcinoma Patients with Microvascular Invasion After R0 Resection Could Be Benefited from Prophylactic Transarterial Chemoembolization: A Propensity Score Matching Study. Cancer Management and Research 12, pages 3815-3825.
Read now
Read now
Liming Wang, Bo Chen, Zhuo Li, Xuesong Yao, Mei Liu, Weiqi Rong, Fan Wu, Shengtao Lin, Yunhe Liu, Yiling Zheng, Yexiong Li, Weihu Wang & Jianxiong Wu. (2019) Optimal postoperative adjuvant treatment strategy for HBV-related hepatocellular carcinoma with microvascular invasion: a propensity score analysis. OncoTargets and Therapy 12, pages 1237-1247.
Read now
Read now
Shi-Dong Lu, Lin Li, Xin-Min Liang, Wu Chen, Fu-Li Chen, Lang-Lin Fan, Bhavesh K. Ahir, Wan-Guang Zhang & Jian-Hong Zhong. (2019) Updates and advancements in the management of hepatocellular carcinoma patients after hepatectomy. Expert Review of Gastroenterology & Hepatology 13:11, pages 1077-1088.
Read now
Read now
Lei Wang, Qiao Ke, Manjun Deng, Xin Huang, Jianxing Zeng, Hongzhi Liu, Yuan Yang, Yongyi Zeng, Weiping Zhou & Jingfeng Liu. (2019) Adjuvant transarterial chemoembolization for patients with hepatocellular carcinoma after radical hepatectomy: a real world study. Scandinavian Journal of Gastroenterology 54:11, pages 1403-1411.
Read now
Read now
Lei Wang, Qiao Ke, Nanping Lin, Yongyi Zeng & Jingfeng Liu. (2019) Does postoperative adjuvant transarterial chemoembolization benefit for all patients with hepatocellular carcinoma combined with microvascular invasion: a meta-analysis. Scandinavian Journal of Gastroenterology 54:5, pages 528-537.
Read now
Read now
Freliska Lazuardi, Jacqueline Valencia & Shusen Zheng. (2019) Adjuvant transcatheter arterial chemoembolization after radical resection of hepatocellular carcinoma patients with tumor size less than 5 cm: a retrospective study. Scandinavian Journal of Gastroenterology 54:5, pages 617-622.
Read now
Read now
Peng Sheng Yi, Yong Li, Shu Yan, Bin Wu, Chuan Lan & Jian Shui Li. (2019) Surgery combined with post-operative trancatheter arterial chemoembolization improves survival of intermediate hepatocellular carcinoma. Scandinavian Journal of Gastroenterology 54:2, pages 240-245.
Read now
Read now
Articles from other publishers (40)
Yangyang OuTao LiuTaiyun HuangZhaosong XueMing YaoJianjun LiYubin HuangXiaoyong CaiYihe Yan. (2023) Risk Factors and Long-Term Implications of Unplanned Conversion During Laparoscopic Liver Resection for Hepatocellular Carcinoma. Journal of Laparoendoscopic & Advanced Surgical Techniques 33:11, pages 1088-1096.
Crossref
Crossref
Zhi-Xi Li, Qi-Fan Zhang, Jia-Ming Huang, Shao-Jian Huang, Han-Biao Liang, Hao Chen, Zhan-Hong Lai, Qing-Yan Li, Jian-Ping Qian, Kai Wang & Jie Zhou. (2023) Safety and efficacy of postoperative adjuvant therapy with atezolizumab and bevacizumab after radical resection of hepatocellular carcinoma. Clinics and Research in Hepatology and Gastroenterology 47:7, pages 102165.
Crossref
Crossref
Kun Zhang, Lei Zhang, Wen-Cui Li, Shuang-Shuang Xie, Ying-Zhu Cui, Li-Ying Lin, Zhi-Wei Shen, Hui-Mao Zhang, Shuang Xia, Zhao-Xiang Ye, Kan He & Wen Shen. (2023) Radiomics nomogram for the prediction of microvascular invasion of HCC and patients’ benefit from postoperative adjuvant TACE: a multi-center study. European Radiology 33:12, pages 8936-8947.
Crossref
Crossref
Long-Hai Feng, Yu-Yao Zhu, Jia-Min Zhou, Miao Wang, Wei-Qi Xu, Ti Zhang, An-Rong Mao, Wen-Ming Cong, Hui Dong & Lu Wang. (2023) Adjuvant TACE may not improve recurrence-free or overall survival in HCC patients with low risk of recurrence after hepatectomy. Frontiers in Oncology 13.
Crossref
Crossref
Ali Mo, Qiao Zhang, Feng Xia, Zhiyuan Huang, Shasha Peng, Wenjing Cao, Hongliang Mei, Li Ren, Yang Su, Hengyi Gao & Weiqiang Chen. (2022) Preoperative transcatheter arterial chemoembolization and prognosis of patients with solitary large hepatocellular carcinomas (≥5 cm): Multicenter retrospective study. Cancer Medicine 12:7, pages 7734-7747.
Crossref
Crossref
. (2023) 2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma. Journal of Liver Cancer 23:1, pages 1-120.
Crossref
Crossref
Liuhua Long, Bo Chen, Hongzhi Wang, Yuting Zhao, Fan Wu, Liming Wang, Weiqi Rong, Jianxiong Wu, Yexiong Li & Weihu Wang. (2023) Survival benefit of radiotherapy following narrow-margin hepatectomy in patients with hepatocellular carcinoma: A propensity score-matched analysis based on phase II study. Radiotherapy and Oncology 180, pages 109462.
Crossref
Crossref
Chao Jiang, Xiao-Dong Sun, Wei Qiu, Yu-Guo Chen, Da-Wei Sun & Guo-Yue Lv. (2023) Conversion therapy in liver transplantation for hepatocellular carcinoma: What's new in the era of molecular and immune therapy?. Hepatobiliary & Pancreatic Diseases International 22:1, pages 7-13.
Crossref
Crossref
Jing Liang, Yi Bai, Fu-Shuang Ha, Ying Luo, Hui-Ting Deng & Ying-Tang Gao. (2023) Combining local regional therapy and systemic therapy: Expected changes in the treatment landscape of recurrent hepatocellular carcinoma. World Journal of Gastrointestinal Oncology 15:1, pages 1-18.
Crossref
Crossref
Nanping Lin, Lei Wang, Qizhen Huang, Weiping Zhou, Xiaolong Liu & Jingfeng Liu. (2022) A simplified model for prophylactic transarterial chemoembolization after resection for patients with hepatocellular carcinoma. PLOS ONE 17:10, pages e0276627.
Crossref
Crossref
. (2022) 2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma. Clinical and Molecular Hepatology 28:4, pages 583-705.
Crossref
Crossref
Qiao Zhang, Feng Xia, Ali Mo, Weiming He, Jiazhen Chen, Weiqiao Zhang & Weiqiang Chen. (2022) Guiding Value of Circulating Tumor Cells for Preoperative Transcatheter Arterial Embolization in Solitary Large Hepatocellular Carcinoma: A Single-Center Retrospective Clinical Study. Frontiers in Oncology 12.
Crossref
Crossref
Alvina Jada Fok, Wong Hoi She, Ka Wing Ma, Simon H. Y. Tsang, Wing Chiu Dai, Albert C. Y. Chan, Chung Mau Lo & Tan To Cheung. (2021) Adjuvant transarterial chemotherapy for margin-positive resection of hepatocellular carcinoma—a propensity score matched analysis. Langenbeck's Archives of Surgery 407:1, pages 245-257.
Crossref
Crossref
. (2022) 2022 KLCA-NCC Korea Practice Guidelines for the Management of Hepatocellular Carcinoma. Korean Journal of Radiology 23:12, pages 1126.
Crossref
Crossref
Jiarui Yang, Hao Liang, Kunpeng Hu, Zhiyong Xiong, Mingbo Cao, Zhaozhong Zhong, Zhicheng Yao & Meihai Deng. (2021) The effects of several postoperative adjuvant therapies for hepatocellular carcinoma patients with microvascular invasion after curative resection: a systematic review and meta-analysis. Cancer Cell International 21:1.
Crossref
Crossref
Qiao Ke, Fu Xiang, Chunhong Xiao, Qizhen Huang, Xiaolong Liu, Yongyi Zeng, Lei Wang & Jingfeng Liu. (2021) Exploring the clinical value of preoperative serum gamma-glutamyl transferase levels in the management of patients with hepatocellular carcinoma receiving postoperative adjuvant transarterial chemoembolization. BMC Cancer 21:1.
Crossref
Crossref
Ahmed N. Elfadaly, Diamantis I. Tsilimigras, J. Madison Hyer, Alessandro Paro, Fabio Bagante, Francesca Ratti, Hugo P. Marques, Olivier Soubrane, Vincent Lam, George A. Poultsides, Irinel Popescu, Sorin Alexandrescu, Guillaume Martel, Aklile Workneh, Alfredo Guglielmi, Tom Hugh, Luca Aldrighetti, Itaru Endo & Timothy M. Pawlik. (2021) Impact of Tumor Burden Score on Conditional Survival after Curative‐Intent Resection for Hepatocellular Carcinoma: A Multi‐Institutional Analysis. World Journal of Surgery 45:11, pages 3438-3448.
Crossref
Crossref
Bo Chen, Jian‐Xiong Wu, Shu‐Hui Cheng, Li‐Ming Wang, Wei‐Qi Rong, Fan Wu, Shu‐Lian Wang, Jing Jin, Yue‐Ping Liu, Yong‐Wen Song, Hua Ren, Hui Fang, Yuan Tang, Ning Li, Ye‐Xiong Li & Wei‐Hu Wang. (2021) Phase 2 Study of Adjuvant Radiotherapy Following Narrow‐Margin Hepatectomy in Patients With HCC. Hepatology 74:5, pages 2595-2604.
Crossref
Crossref
Stepan M. Esagian, Christos D. Kakos, Emmanouil Giorgakis, Lyle Burdine, J. Camilo Barreto & Michail N. Mavros. (2021) Adjuvant Transarterial Chemoembolization Following Curative-Intent Hepatectomy Versus Hepatectomy Alone for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Cancers 13:12, pages 2984.
Crossref
Crossref
Maria Tampaki, George Vasileios Papatheodoridis & Evangelos Cholongitas. (2021) Intrahepatic recurrence of hepatocellular carcinoma after resection: an update. Clinical Journal of Gastroenterology 14:3, pages 699-713.
Crossref
Crossref
Wei Zhang, Bixiang Zhang & Xiao-ping Chen. (2021) Adjuvant treatment strategy after curative resection for hepatocellular carcinoma. Frontiers of Medicine 15:2, pages 155-169.
Crossref
Crossref
Wentao Wang, Yaxun Guo, Jingtao Zhong, Qi Wang, Xin Wang, Honglong Wei, Jie Li & Peng Xiu. (2021) The clinical significance of microvascular invasion in the surgical planning and postoperative sequential treatment in hepatocellular carcinoma. Scientific Reports 11:1.
Crossref
Crossref
Shaohua Li, Jie Mei, Qiaoxuan Wang, Zhixing Guo, Lianghe Lu, Yihong Ling, Li Xu, Minshan Chen, Lie Zheng, Wenping Lin, Jingwen Zou, Yuhua Wen, Wei Wei & Rongping Guo. (2020) Postoperative Adjuvant Transarterial Infusion Chemotherapy with FOLFOX Could Improve Outcomes of Hepatocellular Carcinoma Patients with Microvascular Invasion: A Preliminary Report of a Phase III, Randomized Controlled Clinical Trial. Annals of Surgical Oncology 27:13, pages 5183-5190.
Crossref
Crossref
Shinichiro Nakada, Marc-Antoine Allard, Maite Lewin, Sameh Awad, Nour Dahbi, Hidetoshi Nitta, Antonio Sa Cunha, Denis Castaing, Eric Vibert, Daniel Cherqui, Masaru Miyazaki, Masayuki Ohtsuka & René Adam. (2020) Ischemic Cholangiopathy Following Transcatheter Arterial Chemoembolization for Recurrent Hepatocellular Carcinoma After Hepatectomy: an Underestimated and Devastating Complication. Journal of Gastrointestinal Surgery 24:11, pages 2517-2525.
Crossref
Crossref
Petia Jeliazkova, Andreas Umgelter, Rickmer Braren, Georgios Kaissis, Mona Mustafa & Henrik Einwächter. (2019) Prognostic factors in hepatocellular carcinoma patients undergoing transarterial chemoembolization and radioembolization: a retrospective study. European Journal of Gastroenterology & Hepatology 32:8, pages 1036-1041.
Crossref
Crossref
Peng‐Xiang Wang, Yun‐Fan Sun, Kai‐Qian Zhou, Jian‐Wen Cheng, Bo Hu, Wei Guo, Yue Yin, Jun‐Feng Huang, Jian Zhou, Jia Fan, Tan To Cheung, Xu‐Dong Qu & Xin‐Rong Yang. (2020) Circulating tumor cells are an indicator for the administration of adjuvant transarterial chemoembolization in hepatocellular carcinoma: A single‐center, retrospective, propensity‐matched study. Clinical and Translational Medicine 10:3.
Crossref
Crossref
Lian Li, Bo Li & Ming Zhang. (2019) Postoperative adjuvant transarterial chemoembolization improves the prognosis of hepatocellular carcinoma patients with microvascular invasion: a systematic review and meta-analysis. Acta Radiologica 61:6, pages 723-731.
Crossref
Crossref
Wen Chen, Tao Ma, Jian Zhang, Xiaozhen Zhang, Wei Chen, Yinan Shen, Xueli Bai & Tingbo Liang. (2020) A systematic review and meta-analysis of adjuvant transarterial chemoembolization after curative resection for patients with hepatocellular carcinoma. HPB 22:6, pages 795-808.
Crossref
Crossref
Jian Huang, Fu-Chen Liu, Li Li, Sheng-Xian Yuan, Yuan Yang, Bei-Ge Jiang, Hui Liu & Ze-Ya Pan. (2020) Prognostic Nomogram for Hepatitis B Virus–related Hepatocellular Carcinoma With Adjuvant Transarterial Chemoembolization After Radical Resection. American Journal of Clinical Oncology 43:1, pages 20-27.
Crossref
Crossref
Zhen Zhang, Hanyu Jiang, Jie Chen, Yi Wei, Likun Cao, Zheng Ye, Xin Li, Ling Ma & Bin Song. (2019) Hepatocellular carcinoma: radiomics nomogram on gadoxetic acid-enhanced MR imaging for early postoperative recurrence prediction. Cancer Imaging 19:1.
Crossref
Crossref
Yuntong Li, Bingfen Ma, Zhenyu Yin, Pingguo Liu, Jianming Liu, Jie Li, Fuqiang Wang & Huimin Chen. (2019) Competing endogenous RNA network and prognostic nomograms for hepatocellular carcinoma patients who underwent R0 resection. Journal of Cellular Physiology 234:11, pages 20342-20353.
Crossref
Crossref
Clifford Akateh, Sylvester M Black, Lanla Conteh, Eric D Miller, Anne Noonan, Eric Elliott, Timothy M Pawlik, Allan Tsung & Jordan M Cloyd. (2019) Neoadjuvant and adjuvant treatment strategies for hepatocellular carcinoma. World Journal of Gastroenterology 25:28, pages 3704-3721.
Crossref
Crossref
Haichuan Wang, Hui Cao, Zhong Xu, Dong WangYong Zeng. (2019) SNP rs2596542G>A in MICA is associated with risk of hepatocellular carcinoma: a meta-analysis. Bioscience Reports 39:5.
Crossref
Crossref
KLCA Korean Liver Cancer Association & NCC National Cancer Center. (2019) 2018 Korean Liver Cancer Association–National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma. Gut and Liver 13:3, pages 227-299.
Crossref
Crossref
Shuang Liu, Hui Li, Lei Guo, Bo Zhang, Binghai Zhou, Wentao Zhang, Jian Zhou, Jia Fan & Qinghai Ye. (2019) Tumor Size Affects Efficacy of Adjuvant Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma and Microvascular Invasion. The Oncologist 24:4, pages 513-520.
Crossref
Crossref
Yan-Yan Wang, Li-Jun Wang, Da Xu, Ming Liu, Hong-Wei Wang, Kun Wang, Xu Zhu & Bao-Cai Xing. (2019) Postoperative adjuvant transcatheter arterial chemoembolization should be considered selectively in patients who have hepatocellular carcinoma with microvascular invasion. HPB 21:4, pages 425-433.
Crossref
Crossref
. (2019) 2018 Korean Liver Cancer Association–National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma. Korean Journal of Radiology 20:7, pages 1042.
Crossref
Crossref
Charing Ching-Ning Chong, Siu Tim Cheung, Yue-Sun Cheung, Anthony Wing-Hung Chan, Stephen Lam Chan, Simon Chun-Ho Yu & Paul Bo-San Lai. (2018) Novel biomarkers GEP/ABCB5 regulate response to adjuvant transarterial chemoembolization after curative hepatectomy for hepatocellular carcinoma. Hepatobiliary & Pancreatic Diseases International 17:6, pages 524-530.
Crossref
Crossref
Michael Hsu, Muneeb Ahmed & Ammar Sarwar. (2018) Indications and Best Practices for Intra-arterial Therapies to Treat Hepatocellular Carcinoma. Current Hepatology Reports 17:4, pages 399-411.
Crossref
Crossref
Yanlong Yu, Jiuling Song, Ran Zhang, Zhonghua Liu, Qiang Li, Ying Shi, Ying Chen & Jinming Chen. (2017) Preoperative neutrophil-to-lymphocyte ratio and tumor-related factors to predict microvascular invasion in patients with hepatocellular carcinoma. Oncotarget 8:45, pages 79722-79730.
Crossref
Crossref